Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Cactus
WHD
$4.3B
| $41.7M | 0.04% |
1,088,484
-86,830
| -7% | -$2.97M |
|
277
Terex
TEX
$7.11B
| $41.5M | 0.04% |
1,040,451
-14,718
| -1% | -$598K |
|
278
Zoetis
ZTS
$31.9B
| $41.4M | 0.04% |
451,693
-263,008
| -37% | -$23.3M |
|
|
VIAB
279
DELISTED
Viacom Inc. Class B
VIAB
| $41.3M | 0.04% |
1,224,357
-103,886
| -8% | -$3.12M |
|
|
CLR
280
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $41M | 0.04% |
600,650
-20,257
| -3% | -$1.28M |
|
|
BOLD
281
DELISTED
Audentes Therapeutics, Inc
BOLD
| $40.7M | 0.04% |
1,028,668
+8,112
| +0.8% | +$302K |
|
282
Incyte
INCY
$24.9B
| $40.6M | 0.04% |
587,696
-57,487
| -9% | -$3.95M |
|
|
PNK
283
DELISTED
Pinnacle Entertainment Inc.
PNK
| $40.5M | 0.04% |
1,203,604
-1,075,780
| -47% | -$36.3M |
|
284
Tractor Supply
TSCO
$15.8B
| $40.3M | 0.04% |
2,219,205
+510,370
| +30% | +$8.49M |
|
|
CONE
285
DELISTED
CyrusOne Inc Common Stock
CONE
| $39.8M | 0.04% |
627,025
+323,000
| +106% | +$20.9M |
|
286
Procter & Gamble
PG
$335B
| $39.7M | 0.04% |
477,395
-7,230
| -1% | -$591K |
|
|
ZEN
287
DELISTED
ZENDESK INC
ZEN
| $39.5M | 0.04% |
555,875
+8,618
| +2% | +$550K |
|
288
Kinder Morgan
KMI
$70.5B
| $39.1M | 0.04% |
2,203,396
+1,115,365
| +103% | +$19.9M |
|
289
Agnico Eagle Mines
AEM
$75.4B
| $39M | 0.04% |
1,141,263
-97,939
| -8% | -$3.81M |
|
|
MCRN
290
DELISTED
Milacron Holdings Corp.
MCRN
| $38.9M | 0.04% |
1,921,930
+174,235
| +10% | +$3.53M |
|
|
DBVT
291
DBV Technologies
DBVT
$817M
| $38.9M | 0.04% |
173,129
+2,356
| +1% | +$479K |
|
292
Clorox
CLX
$11.7B
| $38.8M | 0.04% |
258,015
-43,880
| -15% | -$6.23M |
|
293
argenx
ARGX
$54.6B
| $38.8M | 0.04% |
511,221
+179,208
| +54% | +$15.9M |
|
294
Thermo Fisher Scientific
TMO
$214B
| $38.7M | 0.04% |
158,724
-3,964
| -2% | -$912K |
|
295
Enterprise Products Partners
EPD
$82.5B
| $38.7M | 0.04% |
1,346,726
+108,385
| +9% | +$3.13M |
|
296
G-III Apparel Group
GIII
$1.55B
| $38.1M | 0.04% |
791,197
+519,672
| +191% | +$23.6M |
|
|
SEMG
297
DELISTED
SEMGROUP CORPORATION
SEMG
| $38.1M | 0.04% |
1,725,963
+11,829
| +0.7% | +$289K |
|
298
MSC Industrial Direct
MSM
$6.78B
| $37.8M | 0.03% |
429,563
-7,141
| -2% | -$609K |
|
|
NLSN
299
DELISTED
Nielsen Holdings plc
NLSN
| $37.8M | 0.03% |
+1,365,090
| New | +$36.8M |
|
300
Devon Energy
DVN
$50.9B
| $37.5M | 0.03% |
940,162
+68,870
| +8% | +$2.93M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.